DOI: https://dx.doi.org/10.18203/2319-2003.ijbcp20214119
Published: 2021-10-22

Study on drug utilization pattern in conservative management of patients with pancreatitis in a tertiary care teaching hospital

Mohanraj P., Abinaya S., Shalini K., Gopalakrishnan G., Ravichandran K.

Abstract


Background: Drug utilization plays a key role in helping the healthcare system to understand, interpret and improve the prescribing, administration and use of medications. The objective of the study was to assess the drug utilization pattern of drugs prescribed in conservative management of pancreatitis patients in a tertiary care teaching hospital.

Methods: This prospective observational study was conducted in department of surgery, Rajah Muthiah Medical College and Hospital, Annamalai University. The study period was six months from November 2019 to April 2020. A total of 115 patients were selected based on inclusion and exclusion criteria.

Results: The study population containing of 90% (n=104) males and 10% (n=11) females were included in the study. Most of the patients between age group of 25-44 years (48%). The most common etiology was alcoholic 68% (n=78). 7% of population with comorbidities (5% hypertension, 2% diabetes mellitus). In analgesics, tramadol (28%) and in antibiotics cefotaxime 21% was most prescribed. Lactated ringer solution (36%) was prescribed most as intravenous hydration. 7% (n=8) and 3% (n=4) of patients receiving enteral nutrition and parenteral nutrition. The average number of drugs per prescription was 8.5. Out of 1205 drugs, 61% of drugs prescribed in generic form, 39% were prescribed in brand name. The study analyzed that 69% of drugs were prescribed from essential drugs list (EDL) 2019 and 84% drugs prescribed from national list of essential medicines (NLEM) 2015. Number of prescriptions with injection were 79.07%. The overall antibiotic encounter rate 15%. Prescribed daily dose/defined daily dose (PDD/DDD) ratio of folic acid was 5.

Conclusions: Drug utilization study can help in evaluating the quality of care given to the pancreatitis patients and promote rational use of medicines.


Keywords


Drug utilization, Defined daily dose, Prescribed daily dose, Prescribing pattern, Pancreatitis

Full Text:

PDF

References


World Health Organization. Introduction to drug utilization research. 2003. Available at: https://apps.who.int/iris/handle/10665/42627. Accessed on 17 July 2021.

Dinesh Kumar Meena M. Jayanthi-Drug Utilization research: a review Int J of Basic Clinical Pharmcol. 2019;8(2):354-61.

World Health Organization. DDD indicators. Available at: https://www.who.int/medicines/regulat ion/medicines-safety/toolkit_indicators/en/index1 .html. Accessed on 17 July 2021.

World Health Organization. Action programme on Essential Drugs and Vaccines. How to investigate drug use in facilities. Selected drug use indicators. WHO. 1993. Available at: https://apps.who.int/ iris/handle/10665/60519. Accessed on 17 June 2021.

Capellà D. Descriptive Tools and Analysis. In Drug Utilization Studies: Methods and Uses. Edited by Dukes MNG. WHO Regional Publications, European Series, No. 45. 1992;55-78.

World health organization. Prescribing indicators. Available at: https://apps.who.int/medicinedocs/ en/d/Js2289e/3.1.html. Accessed on 17 June 2021.

National List of Essential Medicines-2015. Central Drugs Standard. Available at: https://www.cdsco.nic. in/National%20List%20of%20Essential%20Medicine-%20final %20copy.pdf. Accessed on 17 July 2021.

WHO Essential Medicines. 2019. Available at: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf. Accessed on 17 July 2021.

ATC/DDD Index 2012. WHO Collaborating Centre for Drug statistics Methodology Norwegian Institute of Public Health. 2012. Available at: https://www.whocc.no/. Accessed on 17 July 2021.

Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132(5):2022-44.

Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008;168(6):649-56.

Ammann RW, Heitz PU, Klöppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology. 1996;111(1):224-31.

Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Tobacco smoking and the risk of pancreatitis: A systematic review and meta-analysis of prospective studies. Pancreatology. 2019;19(8):1009-22.

Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, Smith B, Banks PA, Conwell DL. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):710-7.

Mirtallo JM, Forbes A, McClave SA, Jensen GL, Waitzberg DL, Davies AR; International Consensus Guideline Committee Pancreatitis Task Force. International consensus guidelines for nutrition therapy in pancreatitis. J Parenter Enteral Nutr. 2012;36(3):284-91.

Gou S, Yang Z, Liu T, Wu H, Wang C. Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2014;18(2):57.

Arshad M, Fayazuddin M, Mudium R, Chavan VR. Drug utilization study among geriatric patients in a tertiary care teaching hospital in south India. Asian J Pharm Clin Res. 2019;12(10):245-8.

Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-15.

Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;(7):CD009179.

Wilder-Smith CH, Hill L, Osler W, O’Keefe S. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci. 1999;44:1107-16.

Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, Gurusamy KS. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;4(4):CD011384.

WHO International Working Group of Drug Statistics Mehtodology. Introduction to drug utilization research. Geneva: WHO collaborating Centre for Drug Utilization Research and Clinical Pharmacology. 2003. Available at: https://apps.who.int/iris/ handle/10665/42627. Accessed on 17 July 2021.